stock rating
BTIG Initiates Coverage of Berkeley Lights With Buy Rating
BTIG said that the firm is emerging as a leader in enabling the characterization of live cells to accelerate development of biotherapeutics and other products.
JP Morgan, Cowen Initiate Coverage of Singular Genomics Systems
Analysts estimated the total addressable market for the San Diego-based next-generation sequencing firm at between $44 billion and $50 billion.
Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
William Blair Initiates Coverage of 10x Genomics With Outperform Rating
Analysts for the investment bank, which co-managed a recent 10x stock offering, said the company could "redefine the way biological analysis is performed."
Evercore ISI Downgrades Twist Bioscience to In-Line Rating
The investment bank said that while Twist's biopharma and DNA-based data storage businesses offer upside, the timelines for generating revenues are unclear.